Sofia K. Gruvberger-Saal

4.1k total citations
28 papers, 2.4k citations indexed

About

Sofia K. Gruvberger-Saal is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Sofia K. Gruvberger-Saal has authored 28 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Sofia K. Gruvberger-Saal's work include Cancer Genomics and Diagnostics (8 papers), BRCA gene mutations in cancer (5 papers) and Cancer and Skin Lesions (5 papers). Sofia K. Gruvberger-Saal is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), BRCA gene mutations in cancer (5 papers) and Cancer and Skin Lesions (5 papers). Sofia K. Gruvberger-Saal collaborates with scholars based in Sweden, United States and Finland. Sofia K. Gruvberger-Saal's co-authors include Lao H. Saal, Åke Borg, Pär‐Ola Bendahl, Mårten Fernö, Markus Ringnér, Dorthe Grabau, Cecilia Hegardt, Kristina Lövgren, Gabriella Honeth and Per Malmström and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Sofia K. Gruvberger-Saal

28 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia K. Gruvberger-Saal Sweden 20 1.3k 1.3k 1.0k 442 357 28 2.4k
Hege G. Russnes Norway 23 1.6k 1.2× 1.1k 0.9× 1.5k 1.5× 397 0.9× 405 1.1× 55 3.0k
Mohammed A. Aleskandarany United Kingdom 36 1.7k 1.3× 1.6k 1.3× 1.5k 1.5× 510 1.2× 315 0.9× 81 3.4k
Jaana Lahti‐Domenici United States 13 1.3k 1.0× 1.1k 0.9× 750 0.7× 252 0.6× 269 0.8× 13 2.3k
Maryou Lambros United Kingdom 23 1.4k 1.0× 1.0k 0.8× 902 0.9× 304 0.7× 280 0.8× 39 2.3k
Patricia Galván Spain 20 947 0.7× 1.4k 1.1× 997 1.0× 671 1.5× 180 0.5× 69 2.4k
Véronique Becette France 18 889 0.7× 1.0k 0.8× 983 1.0× 412 0.9× 281 0.8× 56 2.2k
S. G. Hilsenbeck United States 10 1.2k 0.9× 1.5k 1.2× 703 0.7× 240 0.5× 580 1.6× 16 2.4k
Matthew T. Chang United States 14 1.4k 1.0× 762 0.6× 862 0.9× 571 1.3× 247 0.7× 18 2.3k
Ingrid Hedenfalk Sweden 28 1.1k 0.8× 824 0.7× 852 0.8× 285 0.6× 546 1.5× 78 2.4k
Marjan Iravani United Kingdom 22 1.1k 0.9× 853 0.7× 812 0.8× 250 0.6× 234 0.7× 34 2.1k

Countries citing papers authored by Sofia K. Gruvberger-Saal

Since Specialization
Citations

This map shows the geographic impact of Sofia K. Gruvberger-Saal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia K. Gruvberger-Saal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia K. Gruvberger-Saal more than expected).

Fields of papers citing papers by Sofia K. Gruvberger-Saal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia K. Gruvberger-Saal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia K. Gruvberger-Saal. The network helps show where Sofia K. Gruvberger-Saal may publish in the future.

Co-authorship network of co-authors of Sofia K. Gruvberger-Saal

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia K. Gruvberger-Saal. A scholar is included among the top collaborators of Sofia K. Gruvberger-Saal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia K. Gruvberger-Saal. Sofia K. Gruvberger-Saal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dahlgren, Malin, et al.. (2022). Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors. Scientific Reports. 12(1). 4696–4696. 42 indexed citations
2.
Dahlgren, Malin, Anthony M. George, Christian Brueffer, et al.. (2021). Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer. JNCI Cancer Spectrum. 5(2). 16 indexed citations
3.
She, Qing‐Bai, Sofia K. Gruvberger-Saal, Matthew Maurer, et al.. (2016). Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer. BMC Cancer. 16(1). 25 indexed citations
4.
Winter, Christof, Martin Nilsson, Eric Olsson, et al.. (2016). Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic. Annals of Oncology. 27(8). 1532–1538. 105 indexed citations
5.
Howlin, Jillian, Helena Cirenajwis, Barbara Lettiero, et al.. (2015). Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours. PeerJ. 3. e788–e788. 16 indexed citations
6.
Olsson, Eleonor, Christof Winter, Anthony M. George, et al.. (2015). Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer. PLoS ONE. 10(12). e0144528–e0144528. 5 indexed citations
7.
8.
Olsson, Eleonor, Christof Winter, Anthony M. George, et al.. (2015). Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Molecular Medicine. 7(8). 1034–1047. 349 indexed citations
9.
Bergenfelz, Caroline, Anna-Maria Larsson, Kristoffer von Stedingk, et al.. (2015). Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients. PLoS ONE. 10(5). e0127028–e0127028. 115 indexed citations
10.
Saal, Lao H., Qing‐Bai She, Sofia K. Gruvberger-Saal, et al.. (2013). Abstract 869: PTEN/PI3K oncogenic pathway profiling informs an in vivo synergistic therapeutic model for basal-like breast cancer.. Cancer Research. 73(8_Supplement). 869–869. 2 indexed citations
11.
Kimbung, Siker, Ida Johansson, Kristina Aaltonen, et al.. (2012). Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition. Cancer Letters. 319(2). 232–241. 37 indexed citations
12.
Holm, Karolina, Dorthe Grabau, Kristina Lövgren, et al.. (2012). Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Molecular Oncology. 6(5). 494–506. 123 indexed citations
13.
Olsson, Eleonor, Gabriella Honeth, Pär‐Ola Bendahl, et al.. (2011). CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer. 11(1). 418–418. 173 indexed citations
14.
Horst, Basil A., Sofia K. Gruvberger-Saal, Benjamin D. Hopkins, et al.. (2009). Gab2-Mediated Signaling Promotes Melanoma Metastasis. American Journal Of Pathology. 174(4). 1524–1533. 61 indexed citations
15.
Szabolcs, Matthias, Megan Keniry, Laura J. Simpson, et al.. (2008). Irs2 Inactivation Suppresses Tumor Progression in Pten+/− Mice. American Journal Of Pathology. 174(1). 276–286. 19 indexed citations
16.
Gruvberger-Saal, Sofia K., Pär‐Ola Bendahl, Lao H. Saal, et al.. (2007). Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma. Clinical Cancer Research. 13(7). 1987–1994. 154 indexed citations
17.
Jerevall, Piiha-Lotta, Carina Strand, Sofia K. Gruvberger-Saal, et al.. (2007). Exploring the two-gene ratio in breast cancer—independent roles for HOXB13 and IL17BR in prediction of clinical outcome. Breast Cancer Research and Treatment. 107(2). 225–234. 47 indexed citations
18.
Jumppanen, Mervi, Sofia K. Gruvberger-Saal, Päivikki Kauraniemi, et al.. (2007). Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. Breast Cancer Research. 9(1). R16–R16. 107 indexed citations
19.
Gruvberger-Saal, Sofia K., et al.. (2006). Microarrays in breast cancer research and clinical practice – the future lies ahead. Endocrine Related Cancer. 13(4). 1017–1031. 21 indexed citations
20.
Gruvberger-Saal, Sofia K., Patrik Edén, Markus Ringnér, et al.. (2004). Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles. Molecular Cancer Therapeutics. 3(2). 161–168. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hege G. Russnes Breakdown of academic impact, for papers by Mohammed A. Aleskandarany Breakdown of academic impact, for papers by Jaana Lahti‐Domenici Breakdown of academic impact, for papers by Maryou Lambros Breakdown of academic impact, for papers by Patricia Galván Breakdown of academic impact, for papers by Véronique Becette Breakdown of academic impact, for papers by S. G. Hilsenbeck Breakdown of academic impact, for papers by Matthew T. Chang Breakdown of academic impact, for papers by Ingrid Hedenfalk Breakdown of academic impact, for papers by Marjan Iravani
Rankless by CCL
2026